Valion Bio: issues press release for subsidiary Velocity Bioworks

What happened

• Valion Bio, Inc. (VBIO) announced on Oct 14, 2026 that it issued a press release regarding its wholly owned subsidiary, Velocity Bioworks, Inc. The press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Key details

• Item reported: Item 8.01 Other events — press release issued on Oct 14, 2026 about Velocity Bioworks, Inc.
• Exhibit filed: Exhibit 99.1 is the press release dated Oct 14, 2026.
• Item 9.01 notes exhibits, including Exhibit 99.1 and the 104 Cover Page Interactive Data File (inline XBRL).
• The filing includes a forward-looking statements paragraph identifying terms such as "anticipates," "expects," "estimates," "believes," and "will."

Why it may matter

• Item 8.01 covers other events and, in this filing, documents that the company issued and filed a press release regarding its subsidiary. Item 9.01 covers the filing of related exhibits and interactive data.
• This filing does not explain why the insider traded or why the company acted.